Intellectual Property Proceedings in Federal Court for 2020

Many of the intellectual properties proceedings in Canada are litigated in the Federal Court and Federal Court of Appeal. I have created the following list of proceedings based on listings provided by the Federal Courts website.

The Federal Court identifies the ‘type’ of proceeding (such as ‘Patent Infringement’) which can be used to identify IP proceedings but this is often incomplete because some PM(NOC) applications are coded as generic Judicial Reviews rather than as specifically IP. I have attempted to compensate for this by creating my own list of frequent PM(NOC) litigants and flagging those as IP regardless of the Federal Courts listing. The Federal Court occasionally incorrectly codes proceedings, such as marking proceedings as ‘patent’ when they are clearly a trade-mark proceeding – I have not corrected these errors – which affects the summary statistics contained below.

Return to other litigation statistics.

[Lists generated on January 24, 2020]

Number of Proceedings

[IP is 17.0% of FC proceedings (17 of 100) year-to-date]

[Based on the ‘type’ designated by the Federal Court.]

Number of Proceedings % of IP Type
5 29.4% Patent Infringement
5 29.4% Patented Medicines (NOC) Regulations [Actions]
4 23.5% Trade Mark Infringement
1 5.9% S. 18.1 Application for Judicial Review
1 5.9% Trade Mark Expungement
1 5.9% Copyright Infringement [Actions]

IP Federal Court Proceedings Year To Date

[Click on a column heading to sort.]

File No. Style of Cause Proceeding Type Date Started Firms*
T-2-20 ELITE CONSTRUCTION INC. v. CONSTRUCTION ELITE INC. Trade Mark Infringement 2020-01-02 BIANCHI PRESTA LLP; SAZANT, DAVID;  
T-6-20 ACTIAL FARMACEUTICA S.R.L. v. MINISTER OF HEALTH S. 18.1 Application for Judicial Review 2020-01-03 Deeth Williams Wall; JEPSON, GORDON S;  
T-7-20 AMGEN INC ET AL v. PFIZER CANADA ULC Patent Infringement – (Pegfilgrastim*) 2020-01-03 Bennett Jones LLP; HUSSEY, DOMINIQUE T;  
T-9-20 WORLDWIDE DIAMOND CORPORATION LIMITED v. YAN MU Trade Mark Expungement 2020-01-06  
T-13-20 ANDRITZ LTD ET AL. v. CORTEX NORTH AMERICA CORPORATION Patent Infringement 2020-01-07 Smart & Biggar; NORTON, MATTHEW;  
T-28-20 ASTRAZENECA CANADA INC. ET AL v. SANDOZ CANADA INC. Patented Medicines (NOC) Regulations [Actions] – (Saxagliptin*) 2020-01-09 Smart & Biggar; HAMILTON, J SHELDON;  
T-34-20 AMGEN INC. ET AL v. PURDUE PHARMA Patented Medicines (NOC) Regulations [Actions] – (Pegfilgrastim*) 2020-01-10 TORY’S LLP; SHAUGHNESSY, ANDREW;  
T-53-20 PFIZER CANADA ULC ET AL v. SANDOZ CANADA INC Patented Medicines (NOC) Regulations [Actions] – (Sunitinib*) 2020-01-15 Norton Rose Fulbright Canada; PASPARAKIS, ORESTES;  
T-57-20 LES INVESTISSEMENTS NOLINOR INC. c. CHRONO AVIATION INC. ET AL. Trade Mark Infringement 2020-01-16  
T-59-20 CNH INDUSTRIAL CANADA, LTD. v. VADERSTAD INDUSTRIES INC. Patent Infringement 2020-01-16 McCarthy T├ętrault LLP TOR; MASON, STEVEN;  
T-63-20 JOSEPH TOMELLERI v. THE QUEEN in the right of PROVINCE OF MANITOBA Copyright Infringement [Actions] 2020-01-16  
T-65-20 ASTELLAS PHARMA CANADA INC. ET. AL. v. SANDOZ CANADA INC. Patent Infringement 2020-01-17  
T-71-20 SKIPTHEDISHES RESTAURANT SERVICES INC v. TGONE INC. Trade Mark Infringement 2020-01-20 MCCARTHY TETRAULT LLP; GLOVER, DANIEL GC;  
T-80-20 BRISTOL-MYERS SQUIBB CANADA CO., ET AL v. ACCORD HEALTHCARE INC. Patented Medicines (NOC) Regulations [Actions] 2020-01-22  
T-81-20 BRISTOL-MYERS SQUIBB CANADA CO., ET AL v. ACCORD HEALTHCARE INC. Patented Medicines (NOC) Regulations [Actions] 2020-01-22  
T-91-20 UNIVERSITY OF SASKATCHEWAN et al. v. NEWAGCO Inc. et al. Patent Infringement 2020-01-23  
T-92-20 JUUL LABS, INC. v. WAQAS TARIQ ET AL Trade Mark Infringement 2020-01-23  

[Top]

IP Federal Court Appeal Proceedings Year To Date

[Click on a column heading to sort.]

File No. Style of Cause Proceeding Type Date Started Firms*
A-13-20 VIIV HEALTHCARE COMPANY ET AL v. GILEAD SCIENCES CANADA, INC. Appeal (S.27 – Interloc.) – Patent Act [from T-226-18 – Patent Infringement] – (Dolutegravir*) 2020-01-13 Bereskin & Parr 
A-15-20 TEVA CANADA LIMITED v. BAYER INC ET AL. Appeal (S.27 – Interloc.) – Patent Act – (Xarelto*) [Appeal from T-1960-18] 2020-01-14 OSLER, HOSKIN & HARCOURT LLP; WHITE, J BRADLEY;  
A-16-20 APOTEX INC. v BAYER INC.ET AL Appeal (S.27 – Interloc.) – Patent Act – (Rivaroxaban*) [Appeal from T-2093-18] 2020-01-14 Goodmans LLP; RADOMSKI, HB;  

[Top]

Notes:

  • Firms – The firms listed are either the plaintiff firm as listed by the Federal Court or the firms as can (automatically) be identified as appearing on any hearings.
  • Proceedings status – For each proceeding the current status as can best be (automatically) determined is listed. This is based on an automatically review of the docket entries for each proceeding.
  • Patented Medicine – Medicinal ingredients are based on automated analysis and should not be relied upon.

Lists generated on January 24, 2020

Canadian Intellectual Property